Company News

In a concerted effort to deepen expertise and advance patient care, Getz Healthcare Malaysia has collaborated with Boston Scientific, a leading player in medical technology, to revolutionize the treatment of Pulmonary Embolism (PE). Sean Chiang, Loo Qing Ning, and Iris Lim from Getz Healthcare Malaysia recently participated in an Ekos workshop hosted at Boston Scientific's cutting-edge manufacturing plant in Penang.

The workshop served as a pivotal opportunity for the Getz Healthcare Malaysia team to enhance their understanding of Ekos technology. Ekos utilizes ultrasound-assisted thrombolysis to effectively dissolve clots that pose life-threatening risks to patients with Pulmonary Embolism. Renowned as a market leader in its field, Ekos has undergone extensive research and clinical studies, solidifying its reputation as a closely studied and highly effective product.

Pulmonary Embolism is a critical condition characterized by blood clots in the lungs, necessitating swift and precise intervention to mitigate potential complications. Traditional treatment methods often encounter challenges in complete clot dissolution and may carry inherent risks.

Ekos represents a paradigm shift in Pulmonary Embolism treatment, offering a safer and more efficient alternative to conventional thrombolysis. By harnessing ultrasound energy, Ekos enables healthcare professionals to precisely target and dissolve clots while minimizing the risk bleeding. Consequently, patients benefit from improved outcomes and reduced complications.

The partnership between Getz Healthcare Malaysia and Boston Scientific underscores Getz Healthcare's unwavering commitment to advancing medical care and saving lives. By harnessing the collective expertise and resources of both entities, Getz Healthcare leads the charge in broadening access to Ekos technology across healthcare facilities in Malaysia. This strategic initiative not only empowers healthcare providers but also underscores Getz Healthcare's pivotal role in equipping them with the necessary tools to deliver optimal care to patients battling Pulmonary Embolism.